Export

Hydroxycarbamide (hydroxyurea)
Essential medicine status
General description
Hydroxycarbamide (also known as hydroxyurea) is an antineoplastic antimetabolite used in treatment protocols for chronic myeloproliferative disorders, and in the management of sickle cell disease.
Recommendations
Section
Cytotoxic medicines
  • Oral > Solid: 200 mg; 250 mg; 300 mg; 400 mg; 500 mg; 1 g
Section
Other medicines for haemoglobinopathies
  • Oral > Solid: 200 mg; 500 mg; 1 g